Skip to content

MozecTM Rx PTCA Balloon Dilatation Catheter MOZ30020Recalls & reported problems

Meril Life Sciences Private Limited · MozecTM Rx PTCA Balloon Dilatation Catheter, 3.00 mm x 20 mm, Rapid Exchange · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 18904224907901), received between Jan 4, 2018 and Jan 4, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Defective Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Defective Component1
  • Device Issue1
  • Physical Property Issue1

Patient problems

  • No Consequences Or Impact To Patient1
  • Patient Problem/Medical Problem1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 4, 2018Defective Component; Device Issue; Physical Property Issue; Defective Component; Device Issue; Physical Property Issue

    THE BALLOON WOULD NOT INFLATE INSIDE OR OUTSIDE THE BODY. THERE WERE NEITHER PATIENT COMPLICATIONS NOR INJURIES REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient; Patient Problem/Medical Problem

    MAUDE report 7166862 ↗

Other Catheters, Transluminal Coronary Angioplasty, Percutaneous devices

All Catheters, Transluminal Coronary Angioplasty, Percutaneous devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page